Non-small cell lung cancer: Clinical Practice Guidelines in Oncology™

David S. Ettinger, Gerold Bepler, Raphael Bueno, Andrew Chang, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D'Amico, Todd L. Demmy, Steven J. Feigenberg, Frederic W. Grannis, Thierry Jahan, Mohammad Jahanzeb, Anne Kessinger, Ritsuko Komaki, Mark G. Kris, Corey J. Langer, Quynh Thu Le, Renato Martins, Gregory A. Otterson, Francisco RobertDavid J. Sugarbaker, Douglas E. Wood

Research output: Contribution to journalReview articlepeer-review

129 Scopus citations


Lung cancer is still the leading cause of cancer death worldwide, and non-small cell lung cancer accounts for 80% to 85% of all lung cancer cases. Surgery, radiation therapy, and chemotherapy are the 3 modalities commonly used to treat patients with NSCLC and can be used either alone or in combination depending on the disease status. The 2006 NCCN Non-Small Cell Lung Cancer Guidelines provide the latest updates in the management of this disease, including stage regrouping and changes in screening recommendations for high-risk patients and in treatment recommendations for several stages. In addition, principles of systemic therapy were expanded to include adjuvant treatment.

Original languageEnglish (US)
Pages (from-to)548-582
Number of pages35
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number6
StatePublished - Jul 2006


  • Chemotherapy
  • Lung cancer
  • Multimodality therapy
  • NCCN Clinical Practice Guidelines
  • Non-small cell lung cancer
  • Radiation therapy
  • Targeted therapy
  • Thoracic surgery

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Non-small cell lung cancer: Clinical Practice Guidelines in Oncology™'. Together they form a unique fingerprint.

Cite this